M. Sidibé, L. Lourez, and B. Samb, The UNAIDS 90-90-90 target: a clear choice for ending AIDS and for sustainable health and development, Journal of the International AIDS Society, vol.19, issue.1, 2016.
DOI : 10.1016/S2352-3018(16)00037-0

M. Nacher, V. Vantilcke, M. Parriault, A. Van-melle, M. Hanf et al., What is driving the HIV epidemic in French Guiana?, International Journal of STD & AIDS, vol.26, issue.5, pp.359-361, 2010.
DOI : 10.1007/s10461-008-9433-x

, Rapport d'activité 2016. Cayenne: Coordination Régionale de la lutte contre le VIH, COREVIHGuyane, 2017.

J. Stover, T. Brown, R. Puckett, and W. Peerapatanapokin, Updates to the Spectrum/Estimations and Projections Package model for estimating trends and current values for key HIV indicators, AIDS, vol.31, p.31, 2017.
DOI : 10.1097/QAD.0000000000001322

, European Centre for Disease Prevention and Control (ECDC). HIV Modelling Tool, ECDC, 2016.

F. Santé-publique and V. Base-de-données, , 2017.

, CEPIDC Interrogation des données sur les causes de décès de, 1979.

, Santé PubliqueFrance Déclaration obligatoire de l'infection VIH et du SIDA, 2013.

, Santé PubliqueFrance e-DO?Déclaration obligatoire en ligne de l'infection par le VIH et du sida http://invs.santepubliquefrance.fr/Espace-professionnels/Maladies-a-declaration-obligatoire/e-DO- Declaration-obligatoire-en-ligne-de-l-infection-par-le-VIH-et-du-sida, 2015.

M. Nacher, A. Adenis, L. Adriouch, J. Dufour, E. Papot et al., What is AIDS in the Amazon and the Guianas? Establishing the burden of disseminated histoplasmosis. The AmeJTrop Med Hyg, pp.239-240, 2011.

L. Cuzin, D. C. Yazdanpanah, Y. Lert, and F. Cohort, How Long Do Physicians Wait to Start Antiretroviral Treatment in Newly Diagnosed HIV-Infected Patients?, HIV Clinical Trials, vol.24, issue.5, pp.339-342, 2011.
DOI : 10.1371/journal.pone.0013132

F. Nakawa, D. Angelis, D. Quinten, C. Bezemer, and D. Eop, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data, Avenir Health AIM: A Spectrum Module for Creating HIV, pp.653-660, 2009.

A. Gourlay, T. Noori, A. Pharris, M. Axelsson, D. Costagliola et al., The Human Immunodeficiency Virus Continuum of Care in European Union Countries in 2013: Data and Challenges, Clinical Infectious Diseases, vol.63, issue.12, pp.1644-1656, 2017.
DOI : 10.1093/cid/ciw418

M. Nacher, E. Guedj, M. Vaz, T. Nasser, V. Randrianjohany et al., Risk factors for follow-up interruption of HIV patients in French Guiana, Am J Trop Med Hyg, vol.74, pp.915-917, 2006.

, La démographie guyanaise toujours aussi dynamique, INSEE, 2016.

, Worldometers, 2018.

M. Nacher, E. Guedj, M. Vaz, T. Nasser, V. Randrianjohany et al., Risk factors for late HIV diagnosis in French Guiana, AIDS, vol.19, issue.7, pp.727-729, 2005.
DOI : 10.1097/01.aids.0000166096.69811.b7

I. Sangare, A. Adenis, L. Adriouch, M. Levy-loeb, S. Dimanche et al., Paid HIV rapid testing in general medicine private practice in French Guiana: a pilot project, Public Health, vol.151, pp.23-26, 2017.
DOI : 10.1016/j.puhe.2017.06.002
URL : https://hal.archives-ouvertes.fr/inserm-01572575

M. Nacher, L. Adriouch, A. Adenis, M. Hanf, A. Van-melle et al., Risk Factors for Delayed Access to Specialized Care in French Guiana, The American Journal of Tropical Medicine and Hygiene, vol.84, issue.5, pp.806-807, 2011.
DOI : 10.4269/ajtmh.2011.10-0671

A. Mocroft, J. Lundgren, M. Sabin, A. Monforte, N. Brockmeyer et al., Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE), PLoS Medicine, vol.160, issue.1, pp.1001510-1001511, 2013.
DOI : 10.1371/journal.pmed.1001510.s005

M. Nacher, L. Adriouch, A. Van-melle, and M. Parriault, Adenis A. Couppié C. Country of infection among HIV-infected patients born abroad living in French Guiana, PLoS One, vol.https, 2018.